Latest Fda Regulatory Approvals News

Page 1 of 1
Tetratherix Limited has marked a pivotal quarter with a $25 million ASX listing, an exclusive licensing agreement with Bio Optix for ophthalmic devices, and progress on FDA regulatory submissions for its prostate spacer product.
Ada Torres
Ada Torres
23 July 2025